In vitro susceptibilities of 2,656 clinical isolates of Candida spp. to micafungin and caspofungin

Organism (no. of isolates tested) and antifungal agentCumulative % susceptible at a MIC (μg/ml) ofa:
C. albicans (1,476)
C. glabrata (356)
C. tropicalis (269)
C. krusei (63)
C. kefyr (17)
C. parapsilosis (383)
C. guilliermondii (45)
C. lusitaniae (24)
Candida spp. (23)
Total (2,656)
  • a Broth microdilution testing was performed according to CLSI M27-A2 (8), using 24-h incubation and a MIC-2 endpoint.